NPCE icon

Neuropace
NPCE

Overview Fund Activity

24 hedge funds and large institutions have $82M invested in Neuropace in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
9
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
KLC
1
Kent Lake Capital
Nevada
$592K
2
Morgan Stanley
2
Morgan Stanley
New York
$10.5M
3
SCM
3
Soleus Capital Management
Connecticut
$11.3M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$6.93M
5
Millennium Management
5
Millennium Management
New York
$3.4M

Top Sellers

1
American Century Companies
1
American Century Companies
Missouri
$0
2
NCM
2
Nantahala Capital Management
Connecticut
$1.98M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$0
4
TRCT
4
Tower Research Capital (TRC)
New York
$4K
5
BlackRock
5
BlackRock
New York
$151K
Name Market Value Shares Shares
Change 		Shares
Change %
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
– – -23,692 Closed
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
– – -58 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2